Wednesday, June 10, 2026

pharma Β· Crohn's Disease Β· Ulcerative Colitis (UC)

AbbVie

AbbVie clinical programs β€” 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

1 Waukegan Road, North Chicago, Illinois 60064, US HQ
60,084 Employees
NMPA registrant Type
Company details
Intelligence Β· Clinical Programs

AbbVie projects

2 ClinicalTrials.gov programs sponsored by AbbVie.

AbbVie has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ABT-493

    AbbVie

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  2. Navitoclax

    AbbVie

    Acute Lymphoblastic Leukemia (ALL)

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does AbbVie have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.